InMed Pharmaceuticals Explores CBN for Skin Disease Treatment

TipRanksNov 20 16:18 ET

InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System

newsfileNov 19 07:30 ET

InMed Pharmaceuticals | 8-K: InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

SECNov 15 11:28 ET

Express News | InMed Pharmaceuticals Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q4 EPS Results

BenzingaNov 15 08:41 ET

InMed Pharmaceuticals Makes Progress on Alzheimer's Drug

TipRanksNov 14 18:08 ET

InMed Pharmaceuticals GAAP EPS of -$2.17, Revenue of $1.26M

Seeking AlphaNov 14 17:44 ET